Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
The agreement allows Merck to opt out of collaborating on patritumab deruxtecan and raludotatug deruxtecan and elect not to pay the additional $750 million for each molecule.
The agreement allows Merck to opt out of collaborating on patritumab deruxtecan and raludotatug deruxtecan and elect not to pay the additional $750 million for each molecule.
Trastuzumab deruxtecan, also known as Enhertu, is used to treat adults with a type of breast cancer called HER2-low and is the first medicine to be licensed for this type of breast cancer, the SMC said.